MP 20 (ERGOLOID 1 mg)
Pill imprint MP 20 has been identified as Ergoloid mesylates 1 mg.
Ergoloid mesylates is used in the treatment of alzheimer's disease; arteriosclerotic dementia; dementia and belongs to the drug class miscellaneous central nervous system agents. FDA has not classified the drug for risk during pregnancy. Ergoloid mesylates 1 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for MP 20
- 1 mg
- 8.00 mm
- Prescription only
- Drug Class:
- Miscellaneous central nervous system agents
- Pregnancy Category:
- N - Not classified
- CSA Schedule:
- N - Not a controlled drug
- Mutual Pharmaceutical Company, Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- butylated hydroxyanisole
hydrogenated cottonseed oil
|NDC Code||Manufacturer / Repackager|
|54868-0899||Physicians Total Care Inc (repackager)|
Note: Inactive ingredients may vary.
More about ergoloid mesylates
- Other brands: Hydergine
- Ergoloid Tablets (FDA)
- Ergoloid Mesylates (Dihydrogenated Ergot Alkaloids; Dihydroergotoxine) (Wolters Kluwer)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.